Clinical Trials Browser

Enrolling by invitation × Docetaxel × 1 year × Clear all

NCT07112209 2025-08-08

Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer

Phase NA Enrolling by invitation

Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer